Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
2016 · Gastric Cancer · 23 citations
https://doi.org/10.1007/s10120-016-0639-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
550
Citations
13
h-index
13
i10-index
Luisa Sánchez‐Lorenzo is an academic researcher from Gobierno de Navarra. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & PARP inhibition in cancer therapy. The author has an h-index of 13, co-authored 57 publications.
ORCID: 0000-0001-9139-6730https://doi.org/10.1007/s10120-016-0639-8
https://doi.org/10.1016/j.soncn.2023.151554
Click to start Chat